News


May 2020

T4M from 05-07/05/2020 in hall 9 booth 9D35, Swiss Pavillion

Convince yourself on site (hall 9, Swiss Pavillon booth 9D35) of the efficiency of our Freeformer and follow live on site how we produce a model from Resomer.

November 2019

Ready for the Medical Future

SAMAPLAST conducted complementary experiments with resorbable materials such as resomer L210S, LR 704, LR 706 S, LG 855 S, C209 and X206S. It has been shown that the process also has only minor IV reductions compared to traditional injection moulding.

November 2019

Absorbable Implant Stabilises Spine

Spine Welding received FDA approval for its screw system for spinal stabilisation. The system includes a bioabsorbable component made by Samaplast.

April 2019

Additive manufactured implants - lot size 1 are the target

3D printing | When can additively manufactured implants be added to, or in some cases even replace, the parts produced by injection molding? The Swiss plastics specialist Samaplast AG has worked on its new technology and successfully completed further long-term tests.

Nov 2018

Lecture by Michael Wildemann in Barcelona

At the trade fair in(3D)ustry in Barcelona, Samaplast AG presented their concept for a presentation on how it meets the market demand for prototypes and small series for medical parts and implants. Special attention in the presentation was on the Arburg Freeformer, with which it is possible to produce generatively manufactured components with standard material from batch size 1 upwards.

March 2018

Prototyping and risk minimization

Prototypes are more and more a necessity in the production of high-precision plastic injection moulded parts for technical products, medical products and implants. This is why we at Samaplast have pushed this development forward together with our customers and partners.

February 2018

Successful test on a permanent implant

Samaplast uses the advantages and synergies of additive manufacturing to minimize the risk during design definition and to shorten the "time-to-market" in the manufacture of medical devices. The aim is to reduce lead times and project costs.